Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DILAUDID 5 MG/5 ML ORAL LIQUID

hydromorphone hydrochloride
$0.8521per ML
DEA Schedule CII

Strength

5 mg/5mL

Manufacturer

Rhodes Pharmaceuticals L.P.

NDC

42858041616

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Last Updated

7/12/2017

Active Ingredients

HYDROMORPHONE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA019891

On Market Since

5/15/2017

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

N/A

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

HYCODAN 5 MG-1.5 MG/5 ML SOLN
Brand
64950034247•Genus Lifesciences Inc.
$0.0505
per ML
HYCODAN 5 MG-1.5 MG TABLET
Brand
64950020503•Genus Lifesciences Inc.
$1.0146
per EA
HYCODAN 5 MG-1.5 MG TABLET
Brand
64950020510•Genus Lifesciences Inc.
$1.0146
per EA
DEMEROL 50 MG/ML SYRINGE
Brand
00409117830•Hospira Inc.
$4.4738
per ML
MS CONTIN ER 15 MG TABLET
Brand
42858051501•Rhodes Pharmaceuticals L.P.
$4.6807
per EA
SUBOXONE 2 MG-0.5 MG SL FILM
Brand
12496120203•Indivior Inc.
$4.7853
per EA
ZUBSOLV 0.7-0.18 MG TABLET SL
Brand
54123090730•Orexo US, Inc.
$5.2599
per EA
ZUBSOLV 1.4-0.36 MG TABLET SL
Brand
54123091430•Orexo US, Inc.
$5.2767
per EA
ROXICODONE 15 MG TABLET
Brand
23635058110•SpecGx LLC
$5.4821
per EA
OXYCONTIN ER 10 MG TABLET
Brand
59011041010•Purdue Pharma LP
$5.8913
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy